Business Practice

Proposed cuts to the funding of US scientific agencies will be detrimental to global health.

If pharma wants to adopt continuous manufacturing, it must employ control procedures to ensure quality.

Joint letter from eight trade associations warns of “supply disruptions to life-saving medicines.”

Will pharma adopt distributed ledger technology for data management within the next five years?

In 100 years, medicine is likely to be vastly different to what we can predict – or even imagine.

Over the past 200 years JM has established itself as a world leader within the Pharma industry

As Article 50's clock continues to tick, will the UK reconsider EEA/EFTA membership?

What do trends in small molecule drugs mean for contract manufacturers?

Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines

Sitting Down With Elisa Cascade, President of Data Solutions at DrugDev